Skip to main content
. 2022 May;10(9):526. doi: 10.21037/atm-22-1076

Figure 2.

Figure 2

Detection of the stemness of NPCOs. (A) IF results for the stem cell markers CD44 and CD133 in the primary and recurrent NPCOs; (B) IHC results of BMI-1 in the primary and recurrent NPCOs and NPC tissues. 40× magnification used for organoid models and 20× for tissues. IF, immunofluorescence; NPCO, nasopharyngeal carcinoma organoid; IHC, immunohistochemistry.